71 for Proposition 71

Proposition 71 is the state ballot initiative that created California's Stem Cell Agency. This month, the Agency reached another milestone when the 71st clinical trial was initiated in the CIRM Alpha Stem Cell Clinics (ASCC) Network. The ASCC Network deploys specialized teams of doctors, nurses and laboratory technicians to conduct stem cell clinical trials at … Continue reading 71 for Proposition 71

Newest member of CIRM Board is a guitar-playing, German Shepherd dog loving, molecular geneticist

The newest member of the CIRM Board is a researcher who wasn't always sure she would have a career as a scientist. Suzanne Sandmeyer, PhD, says at the start of her career she had a lot of doubts. “During my postdoc, I was developing the impression I would struggle to survive in my career as … Continue reading Newest member of CIRM Board is a guitar-playing, German Shepherd dog loving, molecular geneticist

The story behind the book about the Stem Cell Agency

WHY I WROTE “CALIFORNIA CURES”  By Don C. Reed It was Wednesday, June 13th, 2018, the launch day for my new book, “CALIFORNIA CURES: How the California Stem Cell Research Program is Fighting Your Incurable Disease!” As I stood in front of the audience of scientists, CIRM staff members, patient advocates, I thought to myself, … Continue reading The story behind the book about the Stem Cell Agency

CIRM invests in stem cell clinical trial targeting lung cancer and promising research into osteoporosis and incontinence

The five-year survival rate for people diagnosed with the most advanced stage of non-small cell lung cancer (NSCLC) is pretty grim, only between one and 10 percent. To address this devastating condition, the Board of the California Institute for Regenerative Medicine (CIRM) today voted to invest almost $12 million in a team from UCLA that … Continue reading CIRM invests in stem cell clinical trial targeting lung cancer and promising research into osteoporosis and incontinence

Patients at the heart of Alpha Stem Cell Clinics Symposium

I have been to a lot of stem cell conferences over the years and there’s one recent trend I really like: the growing importance and frequency of the role played by patient advocates. There was a time, not so long ago, when having a patient advocate speak at a scientific conference was almost considered a … Continue reading Patients at the heart of Alpha Stem Cell Clinics Symposium

Inspiring Video: UC Irvine Stem Cell Trial Gives Orange County Woman Hope in Her Fight Against ALS

Last week, we lost one of our greatest, most influential scientific minds. Stephen Hawking, a famous British theoretical physicist and author of “A Brief History of Time: From the Big Bang to Black Holes”, passed away at the age of 76. Hawking lived most of his adult life in a wheelchair because he suffered from … Continue reading Inspiring Video: UC Irvine Stem Cell Trial Gives Orange County Woman Hope in Her Fight Against ALS

Video illustrates potential path to stem cell repair for multiple sclerosis

“Can you imagine slowly losing the ability to live life as you know it? To slowly lose the ability to see, to walk, to grab an object, all the while experiencing pain, fatigue and depression?” These sobering questions are posed at the beginning of a recent video produced by Youreka Science and Americans for Cures … Continue reading Video illustrates potential path to stem cell repair for multiple sclerosis

Alpha clinics and a new framework for accelerating stem cell treatments

Last week, at the World Stem Cell Summit in Miami, CIRM took part in a panel discussion about the role and importance of Alpha Clinics in not just delivering stem cell therapies, but in helping create a new, more collaborative approach to medicine. The Alpha Clinic concept is to create  a network of top medical … Continue reading Alpha clinics and a new framework for accelerating stem cell treatments

jCyte Shares Encouraging Update on Clinical Trial for Retinitis Pigmentosa

Stepping out of the darkness into light. That’s how patients are describing their experience after participating in a CIRM-funded clinical trial targeting a rare form of vision loss called retinitis pigmentosa (RP). jCyte, the company conducting the trial, announced 12 month results for its candidate stem cell-based treatment for RP. RP is a genetic disorder … Continue reading jCyte Shares Encouraging Update on Clinical Trial for Retinitis Pigmentosa

The Alpha Stem Cell Clinics: Innovation for Breakthrough Stem Cell Treatments

During this third week of the Month of CIRM, we are focusing on CIRM’s Infrastructure programs which are all focused on helping to accelerate stem cell treatments to patients with unmet medical needs. So here is the question of the day: What is the world’s largest network of medical centers dedicated to providing stem cell … Continue reading The Alpha Stem Cell Clinics: Innovation for Breakthrough Stem Cell Treatments